By German Cannabis Lawyer Kai-Friedrich Niermann and Burkhard Blienert, Political Advisor, former German MP and former drug policy spokesman of the SPD Bundestag’s group.
LATER this month Germany has a unique opportunity to set a ground-breaking new course in European cannabis.
On September 26, the federal elections take place – these will not only result in a new federal government, but also a new Chancellor.
The last cannabis policy reform took place in 1996, when German farmers were again allowed to grow hemp in their fields.
Previous Proposals Shelved Four Years Ago
In 2017, a medical cannabis program was introduced, which now supplies up to 90,000 patients with corresponding medicines.
Prohibition Partners Graphic Demonstrates Vibrancy Of German Medical Cannabis Market – Europe’s Largest
Also in 2017, regulated cannabis distribution was negotiated in the coalition talks after the election, when the Green Party agreed to form a joint government with the Conservatives and the Liberals.
However, the Liberals pulled out of these negotiations at the time, resulting in a new grand coalition and another four years of stalemate on cannabis policy in Germany.
Nevertheless, four years down the line the situation is fundamentally different.
All-Party Support For Reform
All of the parties now represented in the Bundestag are in favour of some kind of cannabis policy reform. Even the resistance of the conservative CDU/CSU now crumbling with senior party figures recently floating the idea of a post-election recreational trial.
International developments in the USA, Canada, Uruguay, Mexico, Liechtenstein and Israel have made it clear that legalising cannabis has exclusively positive effects on society.
The Netherlands, once the world’s liberal pioneer in cannabis, is now also considering legalising recreational use in a pilot project.
Only through regulated distribution and controlled quality can consumer protection be ensured, youth protection guaranteed, tax revenues generated and jobs created.
The black market in the countries that have decided to legalise has been pushed back bit-by-bit, with no country witnessing an increase in consumption.
On the contrary, consumption among young people decreased, and new, older groups of consumers, who had no connection to cannabis before, were added while alcohol consumption has decreased simultaneously.
Industry and investors must therefore prepare for a new regulatory environment in Germany that will offer many opportunities and open up new investment possibilities.
However, the process will not take place overnight; it will, unfortunately be characterised by lengthy debates, hearings and votes.
For all parties with an interest in securing a well-regulated German recreational market it will be necessary to get involved at an early stage.
Prohibition Partners Graphic Illustrates The Growth Of The Medical Cannabis Market
The report describes in detail the positions of the individual parties, the course of the coalition negotiations after the elections in October, and shows a possible time scenario for legalisation in Germany.
It encompasses an overview of the existing black market and, using the Cannabis Control Law mooted by the Greens as a template, explores areas of employee training, the protection of minors, products and product quality, and the number, and minimum distances, for specialist cannabis stores.
It examines the issues around the right to private possession and cultivation and the potential of a revenue-raising cannabis tax.
The course of a possible legislative process, and the possibilities for the industry to actively participate in these processes are also explained in detail, alongside the international obligations from the Single Convention – which Germany must redesign.
For businesses it also speculates on the timeframe and prerequisites that must be met for participation in a future, regulated German cannabis market.
A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.
Home / The Policy Pathway For A Post-Election German Recreational Cannabis Market Outlined In A New Report
The Policy Pathway For A Post-Election German Recreational Cannabis Market Outlined In A New Report
By German Cannabis Lawyer Kai-Friedrich Niermann and Burkhard Blienert, Political Advisor, former German MP and former drug policy spokesman of the SPD Bundestag’s group.
LATER this month Germany has a unique opportunity to set a ground-breaking new course in European cannabis.
On September 26, the federal elections take place – these will not only result in a new federal government, but also a new Chancellor.
The last cannabis policy reform took place in 1996, when German farmers were again allowed to grow hemp in their fields.
Previous Proposals Shelved Four Years Ago
In 2017, a medical cannabis program was introduced, which now supplies up to 90,000 patients with corresponding medicines.
Also in 2017, regulated cannabis distribution was negotiated in the coalition talks after the election, when the Green Party agreed to form a joint government with the Conservatives and the Liberals.
However, the Liberals pulled out of these negotiations at the time, resulting in a new grand coalition and another four years of stalemate on cannabis policy in Germany.
Nevertheless, four years down the line the situation is fundamentally different.
All-Party Support For Reform
All of the parties now represented in the Bundestag are in favour of some kind of cannabis policy reform. Even the resistance of the conservative CDU/CSU now crumbling with senior party figures recently floating the idea of a post-election recreational trial.
International developments in the USA, Canada, Uruguay, Mexico, Liechtenstein and Israel have made it clear that legalising cannabis has exclusively positive effects on society.
The Netherlands, once the world’s liberal pioneer in cannabis, is now also considering legalising recreational use in a pilot project.
Only through regulated distribution and controlled quality can consumer protection be ensured, youth protection guaranteed, tax revenues generated and jobs created.
The black market in the countries that have decided to legalise has been pushed back bit-by-bit, with no country witnessing an increase in consumption.
On the contrary, consumption among young people decreased, and new, older groups of consumers, who had no connection to cannabis before, were added while alcohol consumption has decreased simultaneously.
Industry and investors must therefore prepare for a new regulatory environment in Germany that will offer many opportunities and open up new investment possibilities.
However, the process will not take place overnight; it will, unfortunately be characterised by lengthy debates, hearings and votes.
For all parties with an interest in securing a well-regulated German recreational market it will be necessary to get involved at an early stage.
In order to support the development of this market KFN+ Law Office has produced the Recreational THC Report 2021 for Germany.
The report describes in detail the positions of the individual parties, the course of the coalition negotiations after the elections in October, and shows a possible time scenario for legalisation in Germany.
It encompasses an overview of the existing black market and, using the Cannabis Control Law mooted by the Greens as a template, explores areas of employee training, the protection of minors, products and product quality, and the number, and minimum distances, for specialist cannabis stores.
It examines the issues around the right to private possession and cultivation and the potential of a revenue-raising cannabis tax.
The course of a possible legislative process, and the possibilities for the industry to actively participate in these processes are also explained in detail, alongside the international obligations from the Single Convention – which Germany must redesign.
For businesses it also speculates on the timeframe and prerequisites that must be met for participation in a future, regulated German cannabis market.
For further information on the Recreational THC Report 2021 for Germany visit; https://canna-biz.legal/uebersicht/the-recreational-thc-report-2021-for-germany/.
BusinessCann
Other featured articles
Ananda Pharma Doses First Patient in NIHR-Backed CIPN Trial
By
DEA Rescheduling Hearing Closes as States’ Own Witness Concedes Regulation Reduces Crime
By
Rua Bioscience Signs its Largest-Ever Export Deal With Unnamed UK Cannabis Clinic
By
US Rescheduling Hearing Nears End as Opposition’s Own Witness Acknowledges Cannabis Fits Schedule III Standard
By
Curaleaf Becomes First to Register Cannabis Preparations Under Spain’s New Medical Framework
By
Other featured Adult-Use articles
US Rescheduling Hearing Nears End as Opposition’s Own Witness Acknowledges Cannabis Fits Schedule III Standard
By
Why Medical Companies Win Rescheduling, Whatever Happens to Adult-Use
By
Switzerland Launches Eighth Cannabis Pilot, Testing Home Delivery for the First Time
By
‘A Giant Ship With a Rusty Rudder’: What Six Weeks of Cannabis Rescheduling Has and Hasn’t Changed
By
How Countries Legalise Cannabis Matters More Than Whether They Do, Lancet Review Finds
By
Share Article
The Briefing / Newsletter
Insights
you don't want
to miss.
A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.
Related news
Ananda Pharma Doses First Patient in NIHR-Backed CIPN Trial
By
DEA Rescheduling Hearing Closes as States’ Own Witness Concedes Regulation Reduces Crime
By
Rua Bioscience Signs its Largest-Ever Export Deal With Unnamed UK Cannabis Clinic
By
US Rescheduling Hearing Nears End as Opposition’s Own Witness Acknowledges Cannabis Fits Schedule III Standard
By
Curaleaf Becomes First to Register Cannabis Preparations Under Spain’s New Medical Framework
By
World’s Largest CBD Insomnia Trial Could Hand Avecho an Australian Monopoly
By
Germany Bans Cannabis Flowers from GKV and Mandates Six-Month Trial for Extracts
By
Why Medical Companies Win Rescheduling, Whatever Happens to Adult-Use
By
Cannabis Health Announces Two-City Symposium Series Across Frankfurt and London This Autumn
By